10-K Filing

REGENERON PHARMACEUTICALS, INC. CIK: 872589 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001532176-20-000008`
Period End Date	20191231
Filing Date	20200207
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	regn-123119x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 105 Cash Flow Statement 92 Stockholders Equity 36

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	30.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	30.00M	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.62B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.47B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$812.70M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$1.34B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$1.60B	USD	Point-in-time
Accounts receivable - trade, net	`AccountsReceivableNetCurrent`	$1.72B	USD	Point-in-time
Accounts receivable - trade, net	`AccountsReceivableNetCurrent`	$2.10B	USD	Point-in-time
Accounts receivable from Sanofi	`AccountsReceivableRelatedPartiesCurrent`	$260.60M	USD	Point-in-time
Accounts receivable from Sanofi	`AccountsReceivableRelatedPartiesCurrent`	$226.40M	USD	Point-in-time
Treasury stock, outstanding (in shares)	`TreasuryStockShares`	4.86M	shares	Point-in-time
Treasury stock, outstanding (in shares)	`TreasuryStockShares`	3.99M	shares	Point-in-time
Accounts receivable from Bayer	`AccountsAndNotesReceivableNet`	$311.60M	USD	Point-in-time
Accounts receivable from Bayer	`AccountsAndNotesReceivableNet`	$293.10M	USD	Point-in-time
Inventories	`InventoryNet`	$1.15B	USD	Point-in-time
Inventories	`InventoryNet`	$1.42B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$387.10M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$243.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.69B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.45B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$1.75B	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$3.26B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.89B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.58B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$824.20M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$828.70M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$144.70M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$127.40M	USD	Point-in-time
Total assets	`Assets`	$11.73B	USD	Point-in-time
Total assets	`Assets`	$14.81B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$218.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$418.10M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$772.10M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.09B	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$591.70M	USD	Point-in-time
Deferred revenue, current	`ContractWithCustomerLiabilityCurrent`	$452.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.10B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.44B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$713.90M	USD	Point-in-time
Finance lease liabilities	`CapitalLeaseObligationsNoncurrent`	$708.50M	USD	Point-in-time
Deferred revenue, noncurrent	`ContractWithCustomerLiabilityNoncurrent`	$619.00M	USD	Point-in-time
Deferred revenue, noncurrent	`ContractWithCustomerLiabilityNoncurrent`	$464.20M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$361.70M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$286.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.72B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.98B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$3.91B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$7.38B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.25B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-12.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$21.10M	USD	Point-in-time
Treasury Stock, at cost; 4,860,123 shares in 2019 and 3,990,021 shares in 2018	`TreasuryStockValue`	$396.40M	USD	Point-in-time
Treasury Stock, at cost; 4,860,123 shares in 2019 and 3,990,021 shares in 2018	`TreasuryStockValue`	$739.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.09B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.14B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.76B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$4.45B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.81B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.73B	USD	Point-in-time

Income Statement 105 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.05B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.51B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.66B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.71B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.17B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.61B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.87B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$7.86B	USD	Annual
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.93B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.93B	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.71B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.04B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.19B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.08B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.83B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.56B	USD	Annual
Selling, general, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.32B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.23B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$944.30M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.21B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.62B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$4.18B	USD	Annual
Total expenses	`CostsAndExpenses`	$985.80M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$3.79B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.49B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$1.04B	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$5.65B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.31B	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$2.53B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.08B	USD	Annual
Income from operations	`OperatingIncomeLoss`	$2.21B	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$24.00M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$249.50M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$47.30M	USD	Annual
Interest expense	`InterestExpense`	$25.10M	USD	Annual
Interest expense	`InterestExpense`	$30.20M	USD	Annual
Interest expense	`InterestExpense`	$28.20M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$219.30M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.10M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$19.10M	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.43B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.55B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.08B	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$880.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$109.10M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$313.30M	USD	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$11.27	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$5.12	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$4.23	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$6.12	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$19.38	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$7.25	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$7.58	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$22.65	USD	Annual
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$4.44	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$1.77	USD	1 Quarter
Net income per share - basic (in dollars per share)	`EarningsPerShareBasic`	$5.50	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.16	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.82	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.15	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.86	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.99	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$6.93	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.17	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.68	USD	1 Quarter
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$18.46	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$10.34	USD	Annual
Net income per share - diluted (in dollars per share)	`EarningsPerShareDiluted`	$21.29	USD	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	109.20M	shares	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	106.30M	shares	Annual
Weighted average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	107.90M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	114.80M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	115.90M	shares	Annual
Weighted average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	114.60M	shares	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-7.00M	USD	Annual
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.70M	USD	Annual
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$35.90M	USD	Annual
Unrealized (loss) gain on cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-2.50M	USD	Annual
Unrealized (loss) gain on cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$800.00K	USD	Annual
Unrealized (loss) gain on cash flow hedges	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$700.00K	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.44B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$1.21B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.15B	USD	Annual

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$210.30M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$148.20M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$145.50M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$464.30M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$427.40M	USD	Annual
Non-cash compensation expense	`ShareBasedCompensation`	$507.30M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$-63.50M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$-12.10M	USD	Annual
Other non-cash items, net	`OtherNoncashIncomeExpense`	$29.30M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$140.00M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$130.60M	USD	Annual
Deferred taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-318.80M	USD	Annual
Increase in Sanofi, Bayer, and trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$473.10M	USD	Annual
Increase in Sanofi, Bayer, and trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$362.70M	USD	Annual
Increase in Sanofi, Bayer, and trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$268.90M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$335.50M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$387.90M	USD	Annual
Increase in inventories	`IncreaseDecreaseInInventories`	$314.20M	USD	Annual
Increase in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$130.40M	USD	Annual
Increase in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$113.30M	USD	Annual
Increase in prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$55.70M	USD	Annual
Increase (decrease) in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-194.50M	USD	Annual
Increase (decrease) in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$294.00M	USD	Annual
Increase (decrease) in deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-113.10M	USD	Annual
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$444.50M	USD	Annual
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$210.00M	USD	Annual
Increase (decrease) in accounts payable, accrued expenses, and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-23.20M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$108.60M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-249.30M	USD	Annual
Total adjustments	`AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$314.20M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.31B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.20B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.43B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$1.28B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$3.20B	USD	Annual
Purchases of marketable and other securities	`PaymentsToAcquireMarketableSecurities`	$1.85B	USD	Annual
Sales or maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$544.60M	USD	Annual
Sales or maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.60B	USD	Annual
Sales or maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$775.60M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$429.60M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$383.10M	USD	Annual
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$272.60M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$10.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.03B	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.01B	USD	Annual
Proceeds in connection with finance lease liabilities	`ProceedsFromLongTermCapitalLeaseObligations`	-	USD	Annual
Proceeds in connection with finance lease liabilities	`ProceedsFromLongTermCapitalLeaseObligations`	$57.00M	USD	Annual
Payments in connection with finance lease liabilities	`RepaymentsOfLongTermCapitalLeaseObligations`	-	USD	Annual
Payments in connection with finance lease liabilities	`RepaymentsOfLongTermCapitalLeaseObligations`	$19.90M	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$240.20M	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$114.50M	USD	Annual
Proceeds from issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$211.80M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.20M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$301.70M	USD	Annual
Payments in connection with Common Stock tendered for employee tax obligations	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$188.00M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$275.90M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$4.40M	USD	Annual
Repurchases of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-252.10M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-24.40M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-77.10M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$277.50M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$655.00M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$150.10M	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$547.70M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.48B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$825.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$547.70M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.48B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$825.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$25.00M	USD	Annual
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$22.30M	USD	Annual
Cash paid for interest (net of amounts capitalized)	`InterestPaidNet`	$18.70M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$342.30M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$754.80M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaidNet`	$205.60M	USD	Annual

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$11.09B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$6.14B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.76B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$4.45B	USD	Point-in-time
Issuance of Common Stock for equity awards granted under long-term incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$213.20M	USD	Annual
Issuance of Common Stock for equity awards granted under long-term incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$114.20M	USD	Annual
Issuance of Common Stock for equity awards granted under long-term incentive plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$240.60M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock for employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$188.00M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock for employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.20M	USD	Annual
Common Stock tendered upon exercise of stock options and vesting of restricted stock for employee tax obligations	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$301.70M	USD	Annual
Issuance/distribution of Common Stock for 401(k) Savings Plan	`StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan`	$19.40M	USD	Annual
Issuance/distribution of Common Stock for 401(k) Savings Plan	`StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan`	$38.10M	USD	Annual
Issuance/distribution of Common Stock for 401(k) Savings Plan	`StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan`	$26.90M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$444.80M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$524.60M	USD	Annual
Stock-based compensation charges	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$466.90M	USD	Annual
Net income	`NetIncomeLoss`	$478.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$461.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.12B	USD	Annual
Net income	`NetIncomeLoss`	$792.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$820.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$669.60M	USD	1 Quarter
Net income	`NetIncomeLoss`	$594.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$193.10M	USD	1 Quarter
Net income	`NetIncomeLoss`	$551.40M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.20B	USD	Annual
Net income	`NetIncomeLoss`	$2.44B	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$13.40M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$33.40M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-6.30M	USD	Annual
Repurchases of Common Stock	`StockRepurchasedDuringPeriodValue`	$80.20M	USD	Annual
Repurchases of Common Stock	`StockRepurchasedDuringPeriodValue`	$356.70M	USD	Annual
Ending Balance	`StockholdersEquity`	$11.09B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$6.14B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.76B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$4.45B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.